Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Open-Label, Randomized, Safety, Pharmacokinetic, and Efficacy Study of Voriconazole Inhalation Powder Compared to Oral Voriconazole Tablets in Subjects with Acute Invasive Pulmonary Aspergillosis (IPA)

Next Previous
X
Search
Trial Profile

A Phase 2, Open-Label, Randomized, Safety, Pharmacokinetic, and Efficacy Study of Voriconazole Inhalation Powder Compared to Oral Voriconazole Tablets in Subjects with Acute Invasive Pulmonary Aspergillosis (IPA)

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Voriconazole (Primary) ; Voriconazole
  • Indications Invasive bronchopulmonary aspergillosis
  • Focus Adverse reactions; Registrational
  • Sponsors TFF Pharmaceuticals

    • Most Recent Events

    • 14 May 2024 According to a TFF Pharmaceuticals media release, In Jan 2024, the company presented data from the Phase 2 trial of TFF VORI at the Advances Against Aspergillosis & Mucormycosis (AAAM) Conference, which was held from Jan 25-27, 2024, in Milan, Italy. The data presented at the AAAM Conference were first disclosed by the Company in Dec 2023.
    • 15 Apr 2024 This trial has been completed in Denmark, according to European Clinical Trials Database record.
    • 27 Mar 2024 According to a TFF Pharmaceuticals media release, the company will host a conference call today at 4:30 pm Eastern Time, to discuss updated data for the Voriconazole Inhalation Powder (TFF VORI) program.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top